Astria Therapeutics
ATXS
ATXS
24 hedge funds and large institutions have $35.1M invested in Astria Therapeutics in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
14% less funds holding
Funds holding: 28 → 24 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
24
Holding in Top 10
1
Calls
$9.08M
Puts
–
Top Buyers
| 1 | +$907K | |
| 2 | +$569K | |
| 3 | +$524K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$461K |
| 5 |
JPMorgan Chase & Co
New York
|
+$259K |
Top Sellers
| 1 | -$454K | |
| 2 | -$412K | |
| 3 | -$213K | |
| 4 |
JT
Jump Trading
Chicago,
Illinois
|
-$187K |
| 5 |
OC
Oppenheimer & Co
New York
|
-$187K |